PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA

Reported: April 24, 2019 Initiated: April 11, 2019 #D-1133-2019

Product Description

Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA

Reason for Recall

cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.

Details

Units Affected
33,958 bottles
Distribution
Product was distributed to major distributors and retailers who may have further distribute the product throughout the United States.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 33,958 bottles.
Why was this product recalled?
cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 24, 2019. Severity: Moderate. Recall number: D-1133-2019.